Evaluation of serum biomarkers for patients at increased risk of stroke

International Journal of Vascular Medicine

Volumn 2012, Issue , 2012, Pages

  Jaroslav, Pelisek ^a   Christian, Reeps ^a   Stefan, Ockert ^a   Alexander, Zimmermann ^a   Zepper, Peter ^a   Holger, Poppert ^a   Hans Henning, Eckstein ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; GELATINASE A; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MATRILYSIN; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RISK ASSESSMENT;

EID: 84866241147     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2012/906954     Document Type: Article

References (27)

1. Rothwell P. M., Gutnikov S. A., Warlow C. P., Reanalysis of the final results of the European carotid surgery trial. Stroke 2003 34 2 514 523 2-s2.0-0037319448 10.1161/01.STR.0000054671.71777.C7 (Pubitemid 36206358)
2. Pelisek J., Rudelius M., Zepper P., Poppert H., Reeps C., Schuster T., Eckstein H. H., Multiple biological predictors for vulnerable carotid lesions. Cerebrovascular Diseases 2009 28 6 601 610 2-s2.0-70350070324 10.1159/000247605
3. Virmani R., Burke A. P., Farb A., Kolodgie F. D., Pathology of the Vulnerable Plaque. Journal of the American College of Cardiology 2006 47 8 C13 C18 2-s2.0-33646056999 10.1016/j.jacc.2005.10.065
4. Wahlgren C. M., Zheng W., Shaalan W., Tang J., Bassiouny H. S., Human carotid plaque calcification and vulnerability: relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology. Cerebrovascular Diseases 2009 27 2 193 200 2-s2.0-58149214315 10.1159/000189204
5. Chalela J. A., Evaluating the carotid plaque: going beyond stenosis. Cerebrovascular Diseases 2009 27 1 19 24 2-s2.0-64149110369 10.1159/000200438
6. Moreno P. R., Purushothaman K. R., Sirol M., Levy A. P., Fuster V., Neovascularization in human atherosclerosis. Circulation 2006 113 18 2245 2252 2-s2.0-33646816714 10.1161/CIRCULATIONAHA.105.578955
7. Newby A. C., Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiological Reviews 2005 85 1 1 31 2-s2.0-12844286997 10.1152/physrev.00048.2003 (Pubitemid 40171256)
8. Koenig W., Cardiovascular biomarkers: added value with an integrated approach? Circulation 2007 116 1 3 5 2-s2.0-34347351229 10.1161/CIRCULATIONAHA. 107.707984 (Pubitemid 47016239)
9. Ferri N., Paoletti R., Corsini A., Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation. Current Opinion in Lipidology 2006 17 5 495 501 2-s2.0-33748564043 10.1097/01.mol.0000245254.33011. de (Pubitemid 44372679)
10. Lind L., Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003 169 2 203 214 2-s2.0-0142061128 10.1016/S0021-9150(03) 00012-1 (Pubitemid 37297466)
11. Wu J. T., Wu L. L., Linking inflammation and atherogenesis: soluble markers identified for the detection of risk factors and for early risk assessment. Clinica Chimica Acta 2006 366 1-2 74 80 2-s2.0-33644667767 10.1016/j.cca.2005.10.016 (Pubitemid 43330968)
12. Turu M. M., Krupinski J., Catena E., Rosell A., Montaner J., Rubio F., Alvarez-Sabin J., Cairols M., Badimon L., Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 2006 187 1 161 169 2-s2.0-33744526254 10.1016/j.atherosclerosis. 2005.08.039 (Pubitemid 43817009)
13. Alvarez B., Ruiz C., Chacćn P., Alvarez-Sabin J., Matas M., Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70 carotid artery stenosis. Journal of Vascular Surgery 2004 40 3 469 475 2-s2.0-4444251024 10.1016/j.jvs.2004.06.023 (Pubitemid 39165021)
14. Sapienza P., di Marzo L., Borrelli V., Sterpetti A. V., Mingoli A., Piagnerelli R., Cavallaro A., Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression. European Journal of Vascular and Endovascular Surgery 2004 28 1 89 97 2-s2.0-3242662776 10.1016/j.ejvs.2004.02.022 (Pubitemid 38950144)
15. Molloy K. J., Thompson M. M., Schwalbe E. C., Bell P. R., Naylor A. R., Loftus I. M., Elevation in plasma MMP-9 following carotid endarterectomy is associated with particulate cerebral embolisation. European Journal of Vascular and Endovascular Surgery 2004 27 4 409 413 2-s2.0-1642391443 10.1016/j.ejvs.2004.02.001 (Pubitemid 38386928)
16. Bicknell C. D., Peck D., Lau N. M., Alkhamesi N. A., Cowling M. G., Clark M. W., Jenkins M. P., Wolfe J. H. N., Darzi A. W., Cheshire N. J. W., The relationship between plasma MMP-1, -7, -8 and -13 levels and embolic potential during carotid endoluminal intervention. European Journal of Vascular and Endovascular Surgery 2004 28 5 500 507 2-s2.0-4744366858 10.1016/j.ejvs.2004.06. 020 (Pubitemid 39307442)
17. Heider P., Pelisek J., Poppert H., Eckstein H. H., Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease. Vascular and Endovascular Surgery 2009 43 6 551 560 2-s2.0-74849140257 10.1177/1538574409334826
18. Redgrave J. N., Gallagher P., Lovett J. K., Rothwell P. M., Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke 2008 39 6 1722 1729 2-s2.0-46249096932 10.1161/STROKEAHA.107.507988
19. Redgrave J. N. E., Lovett J. K., Gallagher P. J., Rothwell P. M., Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006 113 19 2320 2328 2-s2.0-33744992900 10.1161/CIRCULATIONAHA.105.589044 (Pubitemid 43947978)
20. Wang T. J., Gona P., Larson M. G., Tofler G. H., Levy D., Newton-Cheh C., Jacques P. F., Rifai N., Selhub J., Robins S. J., Benjamin E. J., D'Agostino R. B., Vasan R. S., Multiple biomarkers for the prediction of first major cardiovascular events and death. The New England Journal of Medicine 2006 355 25 2631 2639 2-s2.0-33845709506 10.1056/NEJMoa055373 (Pubitemid 44969122)
21. Thakore A. H., Guo C. Y., Larson M. G., Corey D., Wang T. J., Vasan R. S., D'Agostino R. B., Lipinska I., Keaney J. F., Benjamin E. J., O'Donnell C. J., Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). American Journal of Cardiology 2007 99 11 1598 1602 2-s2.0-34248663781 10.1016/j.amjcard.2007.01.036 (Pubitemid 46773027)
22. Warlow C., Farrell B., Fraser A., Sandercock P., Slattery J., Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST). The Lancet 1998 351 9113 1379 1387 2-s2.0-0032499446 10.1016/S0140-6736(97)09292-1 (Pubitemid 28209995)
23. DeLong E. R., DeLong D. M., Clarke-Pearson D. L., Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988 44 3 837 845 2-s2.0-0023710206
24. Lemaitre V., D'Armiento J., jmd12@columbia.edu Matrix metalloproteinases in development and disease. Birth Defects Research C 2006 78 1 1 10 10.1002/bdrc.20065 (Pubitemid 43726172)
25. Libby P., Sukhova G., Lee R. T., Galis Z. S., Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. Journal of Cardiovascular Pharmacology 1995 25 2, supplement 2 S9 S12 2-s2.0-0029549156 (Pubitemid 26084648)
26. Chaturvedi S., Bruno A., Feasby T., Holloway R., Benavente O., Cohen S. N., Cote R., Hess D., Saver J., Spence J. D., Stern B., Wilterdink J., Carotid endarterectomyan evidence-based review: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2005 65 6 794 801 2-s2.0-25444454804 10.1212/01.wnl.0000176036.07558. 82 (Pubitemid 41362117)
27. Ito T., Ikeda U., Inflammatory cytokines and cardiovascular disease. Current Drug Targets 2003 2 3 257 265 2-s2.0-0142169939